Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 3

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)

NCT ID: NCT05673148Sponsor: Alliance for Clinical Trials in OncologyLast updated: 2026-06-02

Summary

This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a study is treatment with intravenous (IV) (through a vein) and/or oral medications (systemic therapy) to help stop the cancer sites from getting larger and the spread of the cancer to additional body sites. Ablative means that the intention of the local treatment is to eliminate the cancer at that metastatic site. The ablative local therapy will consist of very focused, intensive radiotherapy called stereotactic ablative radiotherapy (SABR) with or without surgical resection and/or microwave ablation, which is a procedure where a needle is temporarily inserted in the tumor and heat is used to destroy the cancer cells. SABR, surgical resection, and microwave ablation have been tested for safety, but it is not scientifically proven that the addition of these treatments are beneficial for your stage of cancer. The addition of ablative local therapy to all known metastatic sites to the usual approach of systemic therapy could shrink or remove the tumor(s) or prevent the tumor(s) from returning.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate and compare overall survival (OS) (measured from time of randomization) in patients with newly diagnosed oligometastatic colorectal cancer (oCRC) treated with total ablative therapy (TAT) in addition to standard of care (SOC) systemic therapy versus SOC systemic therapy. SECONDARY OBJECTIVES: I. To evaluate and compare event-free survival (EFS) (measured from time of randomization) between the two treatment arms. II. To assess the adverse events (AE) profile within each of the two treatment arms. III. To evaluate the time to local recurrence (TLR) (measured from completion of TAT) in patients with newly diagnosed oCRC treated with TAT + SOC systemic therapy. OUTLINE: Patients are randomized to 1 of 2 arms. ARM 1: Patients undergo TAT on study, consisting of SABR with or without surgical resection and/or microwave ablation. Patients also receive SOC chemotherapy on study. Patients also undergo computed tomography (CT) or magnetic resonance imaging (MRI) or positron emission tomography (PET)/CT scans throughout the trial. ARM 2: Patients receive SOC chemotherapy on study. Patients also undergo Patients also undergo CT or MRI or PET/CT scans throughout the trial.

Arms & interventions

  • ProcedureStereotactic Ablative Radiotherapy

    Undergo SABR

  • ProcedureResection

    undergo surgical resection

  • ProcedureMicrowave Ablation

    undergo microwave ablation

  • DrugChemotherapy

    Receive SOC chemotherapy

  • ProcedureComputed Tomography

    Undergo CT scan

  • ProcedureMagnetic Resonance Imaging

    Undergo MRI

  • ProcedurePositron Emission Tomography

    Undergo PET scan

Outcome measures

Primary

  • Overall Survival (OS)

    o Description: The hazard ratio (HR) for OS will be estimated using a stratified Cox proportional hazards model and the 95% confidence interval (CI) for the HR will be provided. The Kaplan-Meier methodology will be used to estimate the median OS for each treatment arm, and Kaplan-Meier curves will be produced. OS will also be compared between treatment arms using the log rank test

    Time frame: From the date of randomization to the date of death due to all causes, assessed up to 5 years

Secondary

  • Event Free Survival (EFS)

    Time frame: From randomization to the date of first documented progression, recurrence, or death due to all causes, whichever occurs first, assessed up to 5 years

  • • Incidence of Adverse Events (AEs), assessed using National Cancer Institute (NCI) common terminology criteria for adverse events (CTCAE) version 5.0 (v5.0)

    Time frame: Up to 5 years

  • Time to local recurrence (TLR)

    Time frame: from the end of TAT to the date of first documented recurrence at any disease site treated with TAT, assessed up to 5 years after randomization

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * PRE-REGISTRATION (STEP 0): Histologically-confirmed metastatic colorectal adenocarcinoma * PRE-REGISTRATION (STEP 0): No known microsatellite instable (MSI) tumor * PRE-REGISTRATION (STEP 0): No known BRAF V600E mutation * PRE-REGISTRATION (STEP 0): Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression. No known peritoneal and/or omental metastases. If radiologic studies suggest the presence of peritoneal disease, a diagnostic laparoscopy is recommended to verify the absence of peritoneal implants * PRE-REGISTRATION (STEP 0): Primary tumor is already resected OR primary tumor is surgically amenable to resection, as determined by consultation and documentation with surgeon or documentation of discussion in the institutional multi-disciplinary tumor board where a surgeon confirms resectability. Patients with unresectable primary tumors are not eligible * PRE-REGISTRATION (STEP 0): Four (4) or fewer apparent sites of metastatic disease based on review by local medical team of baseline radiographic imaging obtained prior to initiation of systemic therapy. * Sites of metastatic disease must be radiographically evident, but pathologic confirmation is not required. * Liver-only metastatic disease is NOT permitted. For patients with liver metastases, there must be at least one other site of metastasis in addition to the liver to be eligible for this study. * Metastatic lesions must be amenable to any combination of surgical resection, microwave ablation, and/or stereotactic ablative body radiation therapy (SABR). SABR is required for at least one lesion. Therefore, the patient must be seen by a radiation oncologist in consultation to verify eligibility. * Single sites include: * Each hemiliver (right and left), each lobe of the lungs, each adrenal gland, lymph nodes amenable to a single resection or treatment in a single SABR field, bone metastases amenable to treatment in a single SABR field * PRE-REGISTRATION (STEP 0): Patients must have measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 * PRE-REGISTRATION (STEP 0): A maximum of 16 weeks (4 months) of systemic therapy may be administered prior to pre-registration * REGISTRATION (STEP 1): Patients must have no overt evidence of disease progression during systemic therapy prior to registration * REGISTRATION (STEP 1): Not eligible for hepatic artery infusion pump (HAIP) therapy or benefit of HAIP therapy is undefined * REGISTRATION (STEP 1): Patients must have measurable disease per RECIST v1.1 * REGISTRATION (STEP 1): Patients must be receiving (or have received) first-line systemic therapy for metastatic disease for a minimum of 16 weeks (4 months) and a maximum of 24 weeks (6 months) * REGISTRATION (STEP 1): Prior definitive therapy, including adjuvant chemotherapy, must have been completed at least 12 months prior to diagnosis of metastatic disease * REGISTRATION (STEP 1): Not pregnant and not nursing, because this study involves an agent or treatment that has known genotoxic, mutagenic, and teratogenic effects. \* Therefore, for women of childbearing potential only, a negative pregnancy test done =\< 14 days prior to registration is required * REGISTRATION (STEP 1): Age \>= 18 years * REGISTRATION (STEP 1): Eastern Cooperative Oncology Group (ECOG) performance status: 0-2 * REGISTRATION (STEP 1): Absolute neutrophil count (ANC) \>= 1,500/mm\^3 * REGISTRATION (STEP 1): Platelet count \>= 50,000/mm\^3 * REGISTRATION (STEP 1): Creatinine =\< 1.5 x upper limit of normal (ULN) OR calculated (calc.) creatinine clearance \>= 30 mL/min \* Calculated using the Cockcroft-Gault equation * REGISTRATION (STEP 1): Total bilirubin =\< 1.5 x ULN * REGISTRATION (STEP 1): Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic transaminase \[SGOT\]) / alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase \[SGPT\]) =\< 3.0 x ULN \* In the event of metastatic liver disease, =\< 5 x ULN * REGISTRATION (STEP 1): Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial. Note: HIV testing is not required for eligibility * REGISTRATION (STEP 1): No other planned concurrent investigational agents while on study Exclusion Criteria: * N/A

Study locations (184)

Kingman Regional Medical Center

Kingman, Arizona, 86401

Recruiting
Site Public Contact · Contact
John A. Ellerton · Principal Investigator

Mayo Clinic Hospital in Arizona

Phoenix, Arizona, 85054

Recruiting
Site Public Contact · Contact
Christina S. Wu · Principal Investigator

Tower Cancer Research Foundation

Beverly Hills, California, 90211

Recruiting
Site Public Contact · Contact
Jun Gong · Principal Investigator

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

Irvine, California, 92612

Recruiting
Site Public Contact · Contact
Oliver S. Eng · Principal Investigator

Cedars-Sinai Medical Center

Los Angeles, California, 90048

Recruiting
Site Public Contact · Contact
Jun Gong · Principal Investigator

UC Irvine Health/Chao Family Comprehensive Cancer Center

Orange, California, 92868

Recruiting
Site Public Contact · Contact
Oliver S. Eng · Principal Investigator

University of California Davis Comprehensive Cancer Center

Sacramento, California, 95817

Active Not Recruiting

Beebe Medical Center

Lewes, Delaware, 19958

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Beebe South Coastal Health Campus

Millville, Delaware, 19967

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Helen F Graham Cancer Center

Newark, Delaware, 19713

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Medical Oncology Hematology Consultants PA

Newark, Delaware, 19713

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Christiana Care Health System-Christiana Hospital

Newark, Delaware, 19718

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Beebe Health Campus

Rehoboth Beach, Delaware, 19971

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Christiana Care Health System-Wilmington Hospital

Wilmington, Delaware, 19801

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Sibley Memorial Hospital

Washington D.C., District of Columbia, 20016

Active Not Recruiting

George Washington University Medical Center

Washington D.C., District of Columbia, 20037

Recruiting
Site Public Contact · Contact
Sonal Paul · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Coral Gables

Coral Gables, Florida, 33146

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Coral Springs

Coral Springs, Florida, 33065

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Deerfield Beach

Deerfield Beach, Florida, 33442

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Doral

Doral, Florida, 33166

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

UF Health Cancer Institute - Gainesville

Gainesville, Florida, 32610

Recruiting
Site Public Contact · Contact
Thomas J. George · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Hollywood

Hollywood, Florida, 33021

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

Jupiter Medical Center

Jupiter, Florida, 33458

Active Not Recruiting

University of Miami Miller School of Medicine-Sylvester Cancer Center

Miami, Florida, 33136

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

Miami Cancer Institute

Miami, Florida, 33176

Active Not Recruiting

UM Sylvester Comprehensive Cancer Center at Kendall

Miami, Florida, 33176

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

UM Sylvester Comprehensive Cancer Center at Plantation

Plantation, Florida, 33324

Recruiting
Site Public Contact · Contact
Agustin Pimentel · Principal Investigator

Grady Health System

Atlanta, Georgia, 30303

Recruiting
Site Public Contact · Contact
Pretesh R. Patel · Principal Investigator

Emory Proton Therapy Center

Atlanta, Georgia, 30308

Recruiting
Site Public Contact · Contact
Pretesh R. Patel · Principal Investigator

Emory University Hospital Midtown

Atlanta, Georgia, 30308

Recruiting
Site Public Contact · Contact
Pretesh R. Patel · Principal Investigator

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, 30322

Recruiting
Site Public Contact · Contact
Pretesh R. Patel · Principal Investigator

Emory Saint Joseph's Hospital

Atlanta, Georgia, 30342

Recruiting
Site Public Contact · Contact
Pretesh R. Patel · Principal Investigator

Saint Luke's Cancer Institute - Boise

Boise, Idaho, 83712

Recruiting
Site Public Contact · Contact
Alison K. Conlin · Principal Investigator

Saint Luke's Cancer Institute - Fruitland

Fruitland, Idaho, 83619

Recruiting
Site Public Contact · Contact
Alison K. Conlin · Principal Investigator

Saint Luke's Cancer Institute - Meridian

Meridian, Idaho, 83642

Recruiting
Site Public Contact · Contact
Alison K. Conlin · Principal Investigator

Saint Luke's Cancer Institute - Nampa

Nampa, Idaho, 83687

Recruiting
Site Public Contact · Contact
Alison K. Conlin · Principal Investigator

Saint Luke's Cancer Institute - Twin Falls

Twin Falls, Idaho, 83301

Recruiting
Site Public Contact · Contact
Alison K. Conlin · Principal Investigator

University of Illinois

Chicago, Illinois, 60612

Recruiting
Site Public Contact · Contact
Aslam Ejaz · Principal Investigator

Baptist Health Floyd

New Albany, Indiana, 47150

Recruiting
Site Public Contact · Contact
Benjamin Facer · Principal Investigator

UI Health Care Mission Cancer and Blood - Ankeny Clinic

Ankeny, Iowa, 50023

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

University of Iowa Healthcare Cancer Services Quad Cities

Bettendorf, Iowa, 52722

Recruiting
Site Public Contact · Contact
Ioannis A. Voutsadakis · Principal Investigator

Mercy Cancer Center-West Lakes

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

UI Health Care Mission Cancer and Blood - West Des Moines Clinic

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
Seema Harichand-Herdt · Principal Investigator

Greater Regional Medical Center

Creston, Iowa, 50801

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Iowa Methodist Medical Center

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
Seema Harichand-Herdt · Principal Investigator

UI Health Care Mission Cancer and Blood - Des Moines Clinic

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
Seema Harichand-Herdt · Principal Investigator

Mercy Medical Center - Des Moines

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

UI Health Care Mission Cancer and Blood - Laurel Clinic

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
Seema Harichand-Herdt · Principal Investigator

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, Iowa, 52242

Recruiting
Site Public Contact · Contact
Ioannis A. Voutsadakis · Principal Investigator

UI Health Care Mission Cancer and Blood - Waukee Clinic

Waukee, Iowa, 50263

Recruiting
Site Public Contact · Contact
Seema Harichand-Herdt · Principal Investigator

Mercy Medical Center-West Lakes

West Des Moines, Iowa, 50266

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

University of Kentucky/Markey Cancer Center

Lexington, Kentucky, 40536

Active Not Recruiting

Baptist Health Louisville

Louisville, Kentucky, 40207

Recruiting
Site Public Contact · Contact
Benjamin Facer · Principal Investigator

University Medical Center New Orleans

New Orleans, Louisiana, 70112

Recruiting
Site Public Contact · Contact
Kevin M. Sullivan · Principal Investigator

Johns Hopkins University/Sidney Kimmel Cancer Center

Baltimore, Maryland, 21287

Active Not Recruiting

Boston Medical Center

Boston, Massachusetts, 02118

Recruiting
Site Public Contact · Contact
Kimberley S. Mak · Principal Investigator

Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Ann Arbor, Michigan, 48106

Recruiting
Samir Narayan · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Recruiting
Samir Narayan · Principal Investigator

Trinity Health Medical Center - Brighton

Brighton, Michigan, 48114

Recruiting
Samir Narayan · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Recruiting
Samir Narayan · Principal Investigator

Trinity Health Medical Center - Canton

Canton, Michigan, 48188

Recruiting
Samir Narayan · Principal Investigator

Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Samir Narayan · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Samir Narayan · Principal Investigator

Henry Ford Macomb Hospital-Clinton Township

Clinton Township, Michigan, 48038

Active Not Recruiting

Corewell Health Dearborn Hospital

Dearborn, Michigan, 48124

Recruiting
Site Public Contact · Contact
Kuei C. Lee · Principal Investigator

Henry Ford Hospital

Detroit, Michigan, 48202

Recruiting
Site Public Contact · Contact
Adam M. Forman · Principal Investigator

Corewell Health Farmington Hills Hospital

Farmington Hills, Michigan, 48336

Recruiting
Site Public Contact · Contact
Kuei C. Lee · Principal Investigator

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Samir Narayan · Principal Investigator

Hurley Medical Center

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Samir Narayan · Principal Investigator

Allegiance Health

Jackson, Michigan, 49201

Active Not Recruiting

University of Michigan Health - Sparrow Lansing

Lansing, Michigan, 48912

Recruiting
Site Public Contact · Contact
Samir Narayan · Principal Investigator

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

Recruiting
Samir Narayan · Principal Investigator

Henry Ford Health Providence Novi Hospital

Novi, Michigan, 48374

Active Not Recruiting

Corewell Health William Beaumont University Hospital

Royal Oak, Michigan, 48073

Recruiting
Site Public Contact · Contact
Kuei C. Lee · Principal Investigator

Henry Ford Health Providence Southfield Hospital

Southfield, Michigan, 48075

Active Not Recruiting

Corewell Health Beaumont Troy Hospital

Troy, Michigan, 48085

Recruiting
Site Public Contact · Contact
Kuei C. Lee · Principal Investigator

Henry Ford West Bloomfield Hospital

West Bloomfield, Michigan, 48322

Active Not Recruiting

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Recruiting
Samir Narayan · Principal Investigator

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, 56601

Recruiting
Daniel Almquist · Principal Investigator

Regions Hospital

Saint Paul, Minnesota, 55101

Recruiting
Site Public Contact · Contact
Daniel M. Anderson · Principal Investigator

Baptist Memorial Hospital and Cancer Center-Golden Triangle

Columbus, Mississippi, 39705

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

Baptist Cancer Center-Grenada

Grenada, Mississippi, 38901

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

Baptist Memorial Hospital and Cancer Center-Union County

New Albany, Mississippi, 38652

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

Baptist Memorial Hospital and Cancer Center-Oxford

Oxford, Mississippi, 38655

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

Baptist Memorial Hospital and Cancer Center-Desoto

Southhaven, Mississippi, 38671

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

MU Health - University Hospital/Ellis Fischel Cancer Center

Columbia, Missouri, 65212

Recruiting
Site Public Contact · Contact
Mohamed Abdelhakiem · Principal Investigator

Parkland Health Center - Farmington

Farmington, Missouri, 63640

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Heartland Regional Medical Center

Saint Joseph, Missouri, 64506

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri, 63670

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Mercy Hospital Springfield

Springfield, Missouri, 65804

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Mercy Hospital South

St Louis, Missouri, 63128

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Missouri Baptist Medical Center

St Louis, Missouri, 63131

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Mercy Hospital Saint Louis

St Louis, Missouri, 63141

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Missouri Baptist Sullivan Hospital

Sullivan, Missouri, 63080

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

BJC Outpatient Center at Sunset Hills

Sunset Hills, Missouri, 63127

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Billings Clinic Cancer Center

Billings, Montana, 59101

Recruiting
Site Public Contact · Contact
John M. Schallenkamp · Principal Investigator

Benefis Sletten Cancer Institute

Great Falls, Montana, 59405

Recruiting
Site Public Contact · Contact
John M. Schallenkamp · Principal Investigator

Nebraska Medicine-Bellevue

Bellevue, Nebraska, 68123

Recruiting
Site Public Contact · Contact
Laura L. Tenner · Principal Investigator

Nebraska Medicine-Village Pointe

Omaha, Nebraska, 68118

Recruiting
Site Public Contact · Contact
Laura L. Tenner · Principal Investigator

University of Nebraska Medical Center

Omaha, Nebraska, 68198

Recruiting
Site Public Contact · Contact
Laura L. Tenner · Principal Investigator

Renown Regional Medical Center

Reno, Nevada, 89502

Recruiting
Site Public Contact · Contact
John A. Ellerton · Principal Investigator

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center

Lebanon, New Hampshire, 03756

Recruiting
Kathryn C. Hourdequin · Principal Investigator

Memorial Sloan Kettering Basking Ridge

Basking Ridge, New Jersey, 07920

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

Englewood Hospital and Medical Center

Englewood, New Jersey, 07631

Recruiting
Site Public Contact · Contact
Minaxi Jhawer · Principal Investigator

Memorial Sloan Kettering Monmouth

Middletown, New Jersey, 07748

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

Memorial Sloan Kettering Bergen

Montvale, New Jersey, 07645

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

University of New Mexico Cancer Center

Albuquerque, New Mexico, 87106

Recruiting
Benny J. Liem · Principal Investigator

New York-Presbyterian/Brooklyn Methodist Hospital

Brooklyn, New York, 11215

Recruiting
Site Public Contact · Contact
Uqba Khan · Principal Investigator

Memorial Sloan Kettering Commack

Commack, New York, 11725

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

The New York Hospital Medical Center of Queens

Flushing, New York, 11355

Recruiting
Site Public Contact · Contact
Jini Hyun · Principal Investigator

Northwell Health Physicians Partners Radiation Medicine at Queens

Forest Hills, New York, 11375

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Northwell Health Cancer Institute at Huntington

Greenlawn, New York, 11740

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Memorial Sloan Kettering Westchester

Harrison, New York, 10604

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

Northwell Health/Center for Advanced Medicine

Lake Success, New York, 11042

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Northern Westchester Hospital

Mount Kisco, New York, 10549

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Mount Sinai West

New York, New York, 10019

Recruiting
Site Public Contact · Contact
Karyn A. Goodman · Principal Investigator

Mount Sinai Hospital

New York, New York, 10029

Recruiting
Site Public Contact · Contact
Karyn A. Goodman · Principal Investigator

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, New York, 10032

Active Not Recruiting

Manhattan Eye Ear and Throat Hospital

New York, New York, 10065

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Memorial Sloan Kettering Cancer Center

New York, New York, 10065

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

NYP/Weill Cornell Medical Center

New York, New York, 10065

Recruiting
Site Public Contact · Contact
Allyson J. Ocean · Principal Investigator

Lenox Hill Hospital

New York, New York, 10075

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Queens Cancer Center

Rego Park, New York, 11374

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

University of Rochester

Rochester, New York, 14642

Active Not Recruiting

Phelps Memorial Hospital Center

Sleepy Hollow, New York, 10591

Recruiting
Site Public Contact · Contact
Sepideh Gholami · Principal Investigator

Memorial Sloan Kettering Nassau

Uniondale, New York, 11553

Recruiting
Site Public Contact · Contact
Vonetta M. Williams · Principal Investigator

Westchester Medical Center

Valhalla, New York, 10595

Recruiting
Site Public Contact · Contact
Aviva Berkowitz · Principal Investigator

Wilmot Cancer Institute at Webster

Webster, New York, 14580

Active Not Recruiting

Carolinas Medical Center/Levine Cancer Institute

Charlotte, North Carolina, 28203

Recruiting
Site Public Contact · Contact
Christopher D. Corso · Principal Investigator

Atrium Health Cabarrus/LCI-Concord

Concord, North Carolina, 28025

Recruiting
Site Public Contact · Contact
Christopher D. Corso · Principal Investigator

East Carolina University

Greenville, North Carolina, 27834

Recruiting
Site Public Contact · Contact
Aidan M. Burke · Principal Investigator

Sanford Bismarck Medical Center

Bismarck, North Dakota, 58501

Recruiting
Daniel Almquist · Principal Investigator

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Recruiting
Daniel Almquist · Principal Investigator

Sanford Roger Maris Cancer Center

Fargo, North Dakota, 58122

Recruiting
Daniel Almquist · Principal Investigator

Dayton Physicians LLC-Miami Valley South

Centerville, Ohio, 45459

Active Not Recruiting

Miami Valley Hospital South

Centerville, Ohio, 45459

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

MetroHealth Medical Center

Cleveland, Ohio, 44109

Active Not Recruiting

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210

Recruiting
Site Public Contact · Contact
Eric D. Miller · Principal Investigator

Miami Valley Hospital

Dayton, Ohio, 45409

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

Premier Blood and Cancer Center

Dayton, Ohio, 45409

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

Dayton Physician LLC - Englewood

Dayton, Ohio, 45415

Active Not Recruiting

Miami Valley Hospital North

Dayton, Ohio, 45415

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

Atrium Medical Center-Middletown Regional Hospital

Franklin, Ohio, 45005-1066

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

Dayton Physicians LLC-Atrium

Franklin, Ohio, 45005

Active Not Recruiting

Miami Valley Cancer Care and Infusion

Greenville, Ohio, 45331

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

Upper Valley Medical Center

Troy, Ohio, 45373

Recruiting
Site Public Contact · Contact
Tarek M. Sabagh · Principal Investigator

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Active Not Recruiting

Oregon Health and Science University

Portland, Oregon, 97239

Recruiting
Site Public Contact · Contact
Nima Nabavizadeh · Principal Investigator

Christiana Care Health System-Concord Health Center

Chadds Ford, Pennsylvania, 19317

Recruiting
Site Public Contact · Contact
Gregory A. Masters · Principal Investigator

Geisinger Medical Center

Danville, Pennsylvania, 17822

Recruiting
Site Public Contact · Contact
Austin J. Iovoli · Principal Investigator

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, 17033-0850

Recruiting
Site Public Contact · Contact
Zain Siddiqui · Principal Investigator

Lancaster General Ann B Barshinger Cancer Institute

Lancaster, Pennsylvania, 17601

Active Not Recruiting

Geisinger Medical Oncology-Lewisburg

Lewisburg, Pennsylvania, 17837

Recruiting
Site Public Contact · Contact
Austin J. Iovoli · Principal Investigator

Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212

Recruiting
Site Public Contact · Contact
Patrick L. Wagner · Principal Investigator

West Penn Hospital

Pittsburgh, Pennsylvania, 15224

Recruiting
Site Public Contact · Contact
Patrick L. Wagner · Principal Investigator

Geisinger Wyoming Valley/Henry Cancer Center

Wilkes-Barre, Pennsylvania, 18711

Recruiting
Site Public Contact · Contact
Austin J. Iovoli · Principal Investigator

Sanford Cancer Center Oncology Clinic

Sioux Falls, South Dakota, 57104

Recruiting
Daniel Almquist · Principal Investigator

Sanford USD Medical Center - Sioux Falls

Sioux Falls, South Dakota, 57117-5134

Recruiting
Daniel Almquist · Principal Investigator

Baptist Memorial Hospital and Cancer Center-Memphis

Memphis, Tennessee, 38120

Recruiting
Site Public Contact · Contact
Aleksandar Jankov · Principal Investigator

Vanderbilt University/Ingram Cancer Center

Nashville, Tennessee, 37232

Recruiting
Site Public Contact · Contact
Chandrasekhar Padmanabhan · Principal Investigator

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229

Withdrawn

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, 84112

Recruiting
Site Public Contact · Contact
Shane Lloyd · Principal Investigator

Bon Secours Memorial Regional Medical Center

Mechanicsville, Virginia, 23116

Recruiting
Site Public Contact · Contact
Christopher Chipko · Principal Investigator

Bon Secours Saint Francis Medical Center

Midlothian, Virginia, 23114

Recruiting
Site Public Contact · Contact
Christopher Chipko · Principal Investigator

Bon Secours Saint Mary's Hospital

Richmond, Virginia, 23226

Recruiting
Site Public Contact · Contact
Christopher Chipko · Principal Investigator

Bon Secours Cancer Institute at Reynolds Crossing

Richmond, Virginia, 23230

Recruiting
Site Public Contact · Contact
Christopher Chipko · Principal Investigator

Valley Medical Center

Renton, Washington, 98055

Recruiting
Site Public Contact · Contact
John A. Ellerton · Principal Investigator

Edwards Comprehensive Cancer Center

Huntington, West Virginia, 25701

Recruiting
Site Public Contact · Contact
Toni O. Pacioles · Principal Investigator

Langlade Hospital and Cancer Center

Antigo, Wisconsin, 54409

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Ascension Saint Elizabeth Hospital

Appleton, Wisconsin, 54915

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Southeast Wisconsin Hospital - Elmbrook Campus

Brookfield, Wisconsin, 53045

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Calumet Hospital

Chilton, Wisconsin, 53014

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Southeast Wisconsin Hospital - Franklin

Franklin, Wisconsin, 53132

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Columbia Saint Mary's Hospital Ozaukee

Mequon, Wisconsin, 53097

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Southeast Wisconsin Hospital - Saint Joseph Campus

Milwaukee, Wisconsin, 53210

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension Columbia Saint Mary's Hospital - Milwaukee

Milwaukee, Wisconsin, 53211

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226

Recruiting
Site Public Contact · Contact
William A. Hall · Principal Investigator

Ascension Mercy Hospital

Oshkosh, Wisconsin, 54904

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Ascension All Saints Hospital

Racine, Wisconsin, 53405

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Aspirus Cancer Care - James Beck Cancer Center

Rhinelander, Wisconsin, 54501

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Aspirus Cancer Care - Stevens Point

Stevens Point, Wisconsin, 54481

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Aspirus Regional Cancer Center

Wausau, Wisconsin, 54401

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Ascension Medical Group Southeast Wisconsin - Mayfair Road

Wauwatosa, Wisconsin, 53226

Recruiting
Site Public Contact · Contact
Kamal Kant Singh Abbi · Principal Investigator

Aspirus Cancer Care - Wisconsin Rapids

Wisconsin Rapids, Wisconsin, 54494

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

References

  • Hitchcock KE, Miller ED, Shi Q, Dixon JG, Gholami S, White SB, Wu C, Goulet CC, George M, Jee KW, Wright CL, Yaeger R, Shergill A, Hong TS, George TJ, O'Reilly EM, Meyerhardt JA, Romesser PB. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC Cancer. 2024 Feb 13;24(1):201. doi: 10.1186/s12885-024-11899-2.(PubMed)
  • Miller ED, Hitchcock KE, Romesser PB. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies. J Gastrointest Cancer. 2023 Dec;54(4):1116-1127. doi: 10.1007/s12029-022-00900-5. Epub 2023 Jan 18.(PubMed)